VEDOLIZUMAB COMPARED WITH INFLIXIMAB FOR PERIANAL FISTULA CLOSURE IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE

被引：0
|
作者：
Gold, Stephanie
Cohen-Mekelburg, Shirley A.
Schneider, Yecheskel
Bosworth, Brian P.
Scherl, Ellen
Steinlauf, Adam F.
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1725
引用
收藏
页码：S370 / S370
页数：1
相关论文
共 50 条
  • [1] COMBINATION THERAPY WITH VEDOLIZUMAB AND AN IMMUNOMODULATOR IS PREDICTIVE OF IMPROVED PERIANAL FISTULA CLOSURE IN PATIENTS WITH CROHN'S DISEASE
    Gold, Stephanie
    Cohen-Mekelburg, Shirley A.
    Schneider, Yecheskel
    Bosworth, Brian P.
    Steinlauf, Adam F.
    Scherl, Ellen
    GASTROENTEROLOGY, 2018, 154 (06) : S834 - S835
  • [2] Perianal fistula surgical closure in Crohn’s disease
    Kotsiliti E.
    Nature Reviews Gastroenterology & Hepatology, 2022, 19 (6) : 350 - 350
  • [3] Efficacy of Vedolizumab Therapy in Patients With Perianal Crohn's Disease
    Manski, Scott
    Edirisuriya, Chelsea
    Fabrizio, Joseph
    Dioguardi, Vincent
    Gandhi, Hema K.
    Shivashankar, Raina
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S847 - S848
  • [4] Ustekinumab versus Vedolizumab for Moderate to Severe Crohn's Disease
    Singh, Amandeep
    Khan, Freeha
    Lopez, Rocio
    Shen, Bo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S393 - S394
  • [5] Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease
    Yarur, A. J.
    Kanagala, V.
    Stein, D. J.
    Czul, F.
    Quintero, M. A.
    Agrawal, D.
    Patel, A.
    Best, K.
    Fox, C.
    Idstein, K.
    Abreu, M. T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (07) : 933 - 940
  • [6] Surgical methods of fistula closure in fistulating perianal Crohn's disease
    Khalil, Ibraheem
    Bethune, Rob
    COLORECTAL DISEASE, 2023, 25 (03) : 498 - 498
  • [7] Perianal fistula closure with 4 weeks of adalimumab therapy in patients with fistulizing Crohn's disease and a history of intolerance or loss of response to infliximab
    Hinojosa, Joaquin
    Bastida, G.
    Vazquez, N.
    Guerrero, P.
    Castro, B.
    Fernandez, F.
    Gassull, M. A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S457 - S457
  • [8] Combination of vedolizumab and exclusive enteral nutrition in patients with moderate to severe Crohn's Disease
    Kang, J.
    Wang, J.
    Lu, Y.
    Li, J.
    Su, J.
    Ying, A.
    Ren, H.
    Zhou, Q.
    Wang, Y.
    Ding, Y.
    An, P.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 808 - 808
  • [9] The role of vedolizumab in patients with moderate-to-severe Crohn's disease and ulcerative colitis
    Shahidi, Neal
    Bressler, Brian
    Panaccione, Remo
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (03) : 330 - 338
  • [10] Perianal Crohn's disease and infliximab therapy
    McNamara, DA
    Brophy, S
    Hyland, JMP
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2004, 2 (05): : 258 - 263
12345